Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
HIV Medicine
|
March 22, 2021
The shifting picture of HIV treatment, comorbidity and substance use among US MSM living with HIV
G D'Souza, L Benning, V Stosor, et al.
Radiology
|
September 2, 1998
Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients
T M Ernst, L Chang, M D Witt, et al.
Journal of Viral Hepatitis
|
October 4, 2014
Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men
E C Seaberg, M D Witt, L P Jacobson, et al.
HIV Medicine
|
February 3, 2012
Low free testosterone in HIV-infected men is not associated with subclinical cardiovascular disease
A K Monroe, A S Dobs, X Xu, et al.
HIV Medicine
|
May 14, 2015
HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter AIDS Cohort Study (MACS)
T S Metkus, T Brown, M Budoff, et al.
AIDS Care
|
March 17, 2007
The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California
W H Garland, A R Wohl, R Valencia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1996
Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing
M D Witt, R J Lewis, R A Larsen, et al.
The New England Journal of Medicine
|
August 8, 1996
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group
D V Havlir, M P Dubé, F R Sattler, et al.
AIDS (London, England)
|
April 24, 2001
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors
C A Kemper, M D Witt, P H Keiser, et al.
HIV Medicine
|
November 16, 2019
Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations
R M Brusca, D B Hanna, N I Wada, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
HIV Medicine
|
March 22, 2021
The shifting picture of HIV treatment, comorbidity and substance use among US MSM living with HIV
G D'Souza, L Benning, V Stosor, et al.
Radiology
|
September 2, 1998
Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients
T M Ernst, L Chang, M D Witt, et al.
Journal of Viral Hepatitis
|
October 4, 2014
Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men
E C Seaberg, M D Witt, L P Jacobson, et al.
HIV Medicine
|
February 3, 2012
Low free testosterone in HIV-infected men is not associated with subclinical cardiovascular disease
A K Monroe, A S Dobs, X Xu, et al.
HIV Medicine
|
May 14, 2015
HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter AIDS Cohort Study (MACS)
T S Metkus, T Brown, M Budoff, et al.
AIDS Care
|
March 17, 2007
The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California
W H Garland, A R Wohl, R Valencia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1996
Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing
M D Witt, R J Lewis, R A Larsen, et al.
The New England Journal of Medicine
|
August 8, 1996
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group
D V Havlir, M P Dubé, F R Sattler, et al.
AIDS (London, England)
|
April 24, 2001
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors
C A Kemper, M D Witt, P H Keiser, et al.
HIV Medicine
|
November 16, 2019
Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations
R M Brusca, D B Hanna, N I Wada, et al.
Page
of 3